Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 737-747

  Shi, Zhi ^a,b   Yang, Wei Min ^c   Chen, Li Pai ^d   Yang, Dong Hua ^e   Zhou, Qi ^f   Zhu, Jin ^a   Chen, Jun Jiang ^g   Huang, Ruo Chun ^a   Chen, Zhe Sheng ^g   Huang, Ruo Pan ^a,b  

^a RayBiotech   (United States)

^b South China Biochip Research Center   (China)

^c The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e FOX CHASE CANCER CENTER   (United States)

^f SUN YAT SEN UNIVERSITY   (China)

^g ST JOHN'S UNIVERSITY   (United States)

Author keywords

Cytokine; Cytokine antibody arrays; Drug resistance; IL 6; IL 8

Indexed keywords

10 HYDROXYCAMPTOTHECIN; ANGIOGENIN; BONE MORPHOGENETIC PROTEIN 4; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE ANTIBODY; DACTINOMYCIN; DOXORUBICIN; FAS ANTIGEN; FIBROBLAST GROWTH FACTOR 2; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; LEPTIN; MITOMYCIN C; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR BETA SUBUNIT; NEUTRALIZING ANTIBODY; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1; UROKINASE RECEPTOR; VASCULOTROPIN; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMOSENSITIZATION; CYTOKINE PRODUCTION; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, NEUTRALIZING; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CCL2; CYTOKINES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; PACLITAXEL; RECEPTORS, INTERLEUKIN-6; RECEPTORS, INTERLEUKIN-8; RNA, SMALL INTERFERING;

EID: 84866534198     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2196-0     Document Type: Article

References (39)

1. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48-58. doi:10.1038/nrc706 (Pubitemid 37328807)
2. Wu CP, Calcagno AM, Ambudkar SV (2008) Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol 1(2):93-105
3. Tiwari AK, Sodani K, Dai CL, Ashby CR Jr, Chen ZS (2011) Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12(4):570-594
4. Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615-627. doi:10.1146/annurev.med.53.082 901.103929 (Pubitemid 34177898)
5. Baraldi-Junkins CA, Beck AC, Rothstein G (2000) Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol Oncol Clin North Am 14(1):45-61 viii (Pubitemid 30078431)
6. Balkwill FR (1994) Cytokine therapy of cancer. The importance of knowing the context. Eur Cytokine Netw 5(4):379-385
7. Burke F, Relf M, Negus R, Balkwill F (1996) A cytokine profile of normal and malignant ovary. Cytokine 8(7):578-585. doi: 10.1006/cyto.1996.0077 (Pubitemid 26294548)
8. Foti E, Ferrandina G, Martucci R, Romanini ME, Benedetti Panici P, Testa U, Mancuso S, Scambia G (1999) IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels. Oncology 57(3):211-215 (Pubitemid 29481694)
9. Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA (1994) Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 73(7):1882-1888 (Pubitemid 24101966)
10. Negus RP, Balkwill FR (1996) Cytokines in tumour growth, migration and metastasis. World J Urol 14(3):157-165 (Pubitemid 126775157)
11. Fasciani A, D'Ambrogio G, Bocci G, Luisi S, Artini PG, Genazzani AR (2001) Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil Steril 75(6): 1218-1221 (Pubitemid 32522624)
12. Hassan MI, Kassim SK, Saeda L, Laban M, Khalifa A (1999) Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue. Anticancer Res 19(6C):5657-5662 (Pubitemid 30093346)
13. Duan Z, Feller AJ, Penson RT, Chabner BA, Seiden MV (1999) Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin Cancer Res 5(11):3445-3453
14. Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, Duska LR, Fuller AF, Goodman AK, Nikrui N, MacNeill KM, Matulonis UA, Preffer FI, Seiden MV (2000) Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer 10(1):33-41 (Pubitemid 30219476)
15. Bamberger ES, Perrett CW (2002) Angiogenesis in epithelian ovarian cancer. Mol Pathol 55(6):348-359 (Pubitemid 35454510)
16. Sieczkiewicz GJ, Hussain M, Kohn EC (2002) Angiogenesis and metastasis. Cancer Treat Res 107:353-381
17. Huang R, Lin Y, Wang CC, Gano J, Lin B, Shi Q, Boynton A, Burke J, Huang RP (2002) Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res 62(10):2806-2812 (Pubitemid 34525764)
18. Huang RP (2001) Detection of multiple proteins in an antibodybased protein microarray system. J Immunol Methods 255(1-2): 1-13
19. Huang RP (2003) Cytokine antibody arrays: a promising tool to identify molecular targets for drug discovery. Comb Chem High Throughput Screen 6(8):769-775
20. Huang RP, Huang R, Fan Y, Lin Y (2001) Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal Biochem 294(1):55-62. doi:10.1006/abio.2001.5156 (Pubitemid 32612550)
21. Lin Y, Huang R, Chen LP, Lisoukov H, Lu ZH, Li S, Wang CC, Huang RP (2003) Profiling of cytokine expression by biotinlabeled-based protein arrays. Proteomics 3(9):1750-1757. doi: 10.1002/pmic.200300530 (Pubitemid 37129822)
22. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang RP (2004) Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 109(4):507-515. doi:10.1002/ijc.11724 (Pubitemid 38339640)
23. Lin Y, Huang R, Santanam N, Liu YG, Parthasarathy S, Huang RP (2002) Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett 187(1-2):17-24 (Pubitemid 35279328)
24. Wanichkul T, Han S, Huang RP, Sidell N (2003) Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. Fertil Steril 79(Suppl 1):763-769 (Pubitemid 36279682)
25. Huang RP (2004) Cytokine protein arrays. Methods Mol Biol 264:215-231. doi:10.1385/1-59259-759-9:215
26. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72(1):102-109. doi:10.1002/(SICI) 1097-0215(19970703)72:1\102:AID-IJC15[3.0.CO;2-L (Pubitemid 27314646)
27. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED (1995) Egr-1 negatively regulates human tumor cell growth via the DNAbinding domain. Cancer Res 55(21):5054-5062
28. Huang RP, Fan Y, deBelle I, Ni Z, Matheny W, Adamson ED (1998) Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ 5(1):96-106. doi:10.1038/sj.cdd.4400322 (Pubitemid 28359087)
29. Kitazono M, Sumizawa T, Takebayashi Y, Chen ZS, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T, Akiyama S (1999) Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 91(19): 1647-1653 (Pubitemid 29479932)
30. Zeng H, Bain LJ, Belinsky MG, Kruh GD (1999) Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res 59(23):5964-5967 (Pubitemid 30004958)
31. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58(22):5089-5096 (Pubitemid 28521167)
32. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY (2003) Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103(5):642-646. doi:10.1002/ijc.10833 (Pubitemid 36091468)
33. Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C, Mancuso S (1995) Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 71(2):354-356
34. Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincon M (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 61(24): 8851-8858 (Pubitemid 34013900)
35. Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N (1999) Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. Cancer 85(1):134-144. doi:10.1002/ (SICI)1097-0142(19990101)85:1\134:AID-CNCR19[3.0. CO;2-C (Pubitemid 29031367)
36. Duan Z, Lamendola DE, Penson RT, Kronish KM, Seiden MV (2002) Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells. Cytokine 17(5):234-242. doi:10.1006/cyto.2001.1008
37. Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di Gesu G, De Maria R (2003) Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 63(20):6784-6790 (Pubitemid 37322959)
38. Yamagiwa Y, Marienfeld C, Meng F, Holcik M, Patel T (2004) Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival. Cancer Res 64(4):1293-1298 (Pubitemid 38235596)
39. Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T et al. (1994) Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263(5143):89-92 (Pubitemid 24076262)